Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic
  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

MultiPlan Reports Third Quarter 2021 Results and Updates 2021 Guidance

– Q3 2021 Revenues of $288.2 million

– Q3 2021 Net Income of $78.2 million

– Q3 2021 Adjusted EBITDA of $218.4 million

– Q4 2021 Revenue guidance of $285 million to $300 million

– Q4 2021 Adjusted EBITDA guidance of $215 million to $225 million

MultiPlan Corporation (“MultiPlan” or the “Company”) (NYSE: MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry, today reported financial results for the third quarter ended September 30, 2021.

“Since going public a year ago, MultiPlan has produced improved results, quarter after quarter,” said Mark Tabak, CEO of MultiPlan. “We are pleased to have delivered strong growth yet again in the third quarter, with record quarterly results in both Revenues and Adjusted EBITDA, attesting to the recurring nature of our business model, our strong cash generation, our commitment to operational excellence, and the value of our services to payors, providers and patients. Given our strong third quarter results and our outlook for the fourth quarter, we are increasing the midpoint of our guidance for our Full Year 2021 revenues and increasing our guidance for Adjusted EBITDA. I am extremely proud of what our team has achieved, and remain confident in MultiPlan’s future.”

The Company remains focused on its mission of delivering fairness, efficiency and affordability to the U.S. healthcare system and on driving sustained long-term growth by enhancing its product offerings to payors, extending into new payor customer segments, and expanding its platform to serve MultiPlan’s 1.2 million providers, its more than 700 payor customers, and 60 plus million consumers.

Business and Financial Highlights

  • Revenues of $288.2 million for Q3 2021, an increase of 28.9% over Q3 2020 revenues of $223.5 million.
  • Net income of $78.2 million for Q3 2021 compared to net loss of $288.4 million for Q3 2020.
  • Adjusted EBITDA of $218.4 million for Q3 2021, an increase of 31.9% over Q3 2020 Adjusted EBITDA of $165.5 million
  • The Company processed approximately $31.2 billion in claims during the third quarter of 2021, identifying potential medical cost savings of approximately $5.5 billion.
  • Announced a share repurchase authorization of $250 million and repurchased over 19 million shares through the end of October 2021.

2021 Financial Guidance

The Company is increasing the midpoint of our guidance range for Full Year 2021 Revenues and increasing our guidance for Full Year 2021 Adjusted EBITDA, reflecting the combination of: year-to-date results, including stronger-than-anticipated Adjusted EBITDA in Q3 2021, and continued organic growth in revenues driven by a strong pipeline of service implementations with customers. A comparison of the Company’s prior and updated Full Year 2021 guidance is presented in the table below.

Financial Metric

 

Prior FY 2021 Guidance

 

Updated FY 2021 Guidance

Revenues

 

$1,090 million to $1,130 million

 

$1,105 million to $1,120 million

Adj. EBITDA

 

$810 million to $835 million

 

$830 million to $840 million

Cash flow from operations

 

$410 million to $440 million

 

$410 million to $420 million

Capital expenditures

 

$75 million to $80 million

 

$85 million to $90 million

Interest expense

 

$250 million to $260 million

 

$260 million to $270 million

Depreciation

 

$65 million to $70 million

 

$65 million to $70 million

Amortization of intangible assets

 

$335 million to $345 million

 

$335 million to $345 million

Effective tax rate

 

25% to 28%

 

25% to 28%

The Company anticipates Q4 2021 revenues between $285 million and $300 million with Adjusted EBITDA between $215 million and $225 million. The above quarterly and annual guidance reflects an estimated COVID-related revenue impact of $9-11 million and an estimated COVID-related Adjusted EBITDA impact of $7-9 million in Q4 2021, as compared with a revenue impact of $8-10 million in Q3 2021, $9-11 million in Q2 2021, and $18-22 million in Q1 2021, and an estimated Adjusted EBITDA impact of $6-8 million in Q3 2021, $7-9 million in Q2 2021, and $16-18 million in Q1 2021.

Excluding the estimated potential impact of the COVID-19 pandemic and contributions from acquired businesses, the Company’s Full Year 2021 guidance implies a range of revenues of $1,105 million to $1,125 million, compared to a range of revenues of $1,085 million to $1,125 million for the Full Year 2021 estimated forecast provided in the 2020 Proxy Statement. Excluding the estimated potential impact of the COVID-19 pandemic, contributions from acquired businesses, and public company costs, the Company’s guidance implies a range of Adjusted EBITDA of $868 million to $888 million, compared to a range of Adjusted EBITDA of $845 million to $875 million for the Full Year 2021 forecast provided in the 2020 Proxy Statement. The Full Year 2021 estimated forecast provided in the 2020 Proxy Statement was based on numerous variables and assumptions known to the Company at the time of preparation, and these assumptions and variables did not include any estimated potential impact from the COVID-19 pandemic, acquisitions, or public company costs.

Conference Call Information

The Company will host a conference call today, Wednesday, November 3, 2021 at 10:00 a.m. U.S. Eastern Time (ET) to discuss its financial results. Interested investors and other parties can register for the conference call using the link below:

http://www.directeventreg.com/registration/event/7165049

A live webcast of the conference call can be accessed through the Investor Relations section of the Company’s website at investors.multiplan.com/events-and-presentations. Participants should join the webcast ten minutes prior to the start of the conference call. A supplemental slide deck will also be available on this section of the MultiPlan website.

For those unable to listen to the live conference call, a replay will be available approximately two hours after the call through the archived webcast on the Investor Relations section of the Company’s website or by dialing (800) 585-8367 or (416) 621-4642. The conference ID for replay is 7165049.

About MultiPlan

MultiPlan is committed to helping healthcare payors manage the cost of care, improve their competitiveness and inspire positive change. Leveraging sophisticated technology, data analytics and a team rich with industry experience, MultiPlan interprets clients' needs and customizes innovative solutions that combine its payment and revenue integrity, network-based and analytics-based services. MultiPlan is a trusted partner to over 700 healthcare payors in the commercial health, government and property and casualty markets. For more information, visit multiplan.com.

Forward Looking Statements

This press release includes statements that express our and our subsidiaries’ opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results and therefore are, or may be deemed to be, “forward-looking statements”. These forward-looking statements can generally be identified by the use of forward-looking terminology, including the terms “believes,” “estimates,” “anticipates,” “expects,” “seeks,” “projects,” “forecasts,” “intends,” “plans,” “may,” “will” or “should” or, in each case, their negative or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. They appear in a number of places throughout this press release, including the discussion of 2021 guidance and platform expansion, and these forward-looking statements reflect management’s expectations regarding our future growth, results of operations, operational and financial performance and business prospects and opportunities. Such forward-looking statements are based on available current market material and management’s expectations, beliefs and forecasts concerning future events impacting the business. Although we believe that these forward-looking statements are based on reasonable assumptions at the time they are made, you should be aware that many factors could affect our actual financial results, including: the impact from the COVID-19 pandemic and its related effects on our projected results of operations, financial performance or other financial metrics; loss of our customers, particularly our largest customers; decreases in our existing market share or the size of our Preferred Provider Organization networks; effects of competition; effects of pricing pressure; the inability of our customers to pay for our services; decreases in discounts from providers; the loss of our existing relationships with providers; the loss of key members of our management team; pressure to limit access to preferred provider networks; the ability to achieve the goals of our strategic plans and recognize the anticipated strategic, operational, growth and efficiency benefits when expected; our ability to identify, complete and successfully integrate acquisitions; changes in our industry; interruptions or security breaches of our information technology systems; our ability to protect proprietary applications; our inability to expand our network infrastructure; our ability to remediate any material weakness or maintain effective internal controls over financial reporting; changes in our regulatory environment, including healthcare law and regulations; the expansion of privacy and security laws; heightened enforcement activity by government agencies; our ability to pay interest and principal on our notes and other indebtedness; the possibility that we may be adversely affected by other political, economic, business, and/or competitive factors; other factors disclosed in our Securities and Exchange Commission (“SEC”) filings; and other factors beyond our control.

The forward-looking statements contained in this press release are based on our current expectations and beliefs concerning future developments and potential effects on our business. There can be no assurance that future developments affecting our business will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020 and our Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2021, including those under “Risk Factors” therein, and other documents filed or to be filed with the SEC by us. Should one or more of these risks or uncertainties materialize, or should any of the assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Forward-looking statements speak only as of the date made. We do not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

Non-GAAP Financial Measures

In addition to the financial measures prepared in accordance with generally accepted accounting principles in the United States (“GAAP”), this press release contains certain non-GAAP financial measures, including EBITDA, Adjusted EBITDA, Unlevered Free Cash Flow and Adjusted cash conversion ratio. A non-GAAP financial measure is generally defined as a numerical measure of a company’s financial or operating performance that excludes or includes amounts so as to be different than the most directly comparable measure calculated and presented in accordance with GAAP.

EBITDA, Adjusted EBITDA, Unlevered Free Cash Flow and Adjusted cash conversion ratio are supplemental measures of MultiPlan’s performance that are not required by or presented in accordance with GAAP. These measures are not measurements of our financial or operating performance under GAAP, have limitations as analytical tools and should not be considered in isolation or as an alternative to net income (loss), cash flows or any other measures of performance prepared in accordance with GAAP.

EBITDA represents net income (loss) before interest expense, interest income, income tax provision (benefit), depreciation, amortization of intangible assets, and non-income taxes. Adjusted EBITDA is EBITDA as further adjusted by certain items as described in the table below.

In addition, in evaluating EBITDA and Adjusted EBITDA you should be aware that in the future, we may incur expenses similar to the adjustments in the presentation of EBITDA and Adjusted EBITDA. The presentation of EBITDA and Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items. The calculations of EBITDA and Adjusted EBITDA may not be comparable to similarly titled measures reported by other companies. Based on our industry and debt financing experience, we believe that EBITDA and Adjusted EBITDA are customarily used by investors, analysts and other interested parties to provide useful information regarding a company’s ability to service and/or incur indebtedness.

We also believe that Adjusted EBITDA is useful to investors and analysts in assessing our operating performance during the periods these charges were incurred on a consistent basis with the periods during which these charges were not incurred. Both EBITDA and Adjusted EBITDA have limitations as analytical tools, and you should not consider either in isolation, or as a substitute for analysis of our results as reported under GAAP. Some of the limitations are:

  • EBITDA and Adjusted EBITDA do not reflect changes in, or cash requirements for, our working capital needs;
  • EBITDA and Adjusted EBITDA do not reflect interest expense, or the cash requirements necessary to service interest or principal payments on our debt;
  • EBITDA and Adjusted EBITDA do not reflect our tax expense or the cash requirements to pay our taxes; and
  • Although depreciation and amortization are non-cash charges, the tangible assets being depreciated will often have to be replaced in the future, and EBITDA and Adjusted EBITDA do not reflect any cash requirements for such replacements.

​MultiPlan’s presentation of Adjusted EBITDA should not be construed as an inference that our future results and financial position will be unaffected by unusual items.

Unlevered Free Cash Flow is defined as net cash provided by (used in) operating activities less capital expenditures, plus cash interest paid, all as disclosed in the Statements of Cash Flows. Unlevered Free Cash Flow is a measure of our operational performance used by management to evaluate our business prior to the impact of our capital structure and after purchases of property and equipment. Unlevered Free Cash Flow should be considered in addition to, rather than as a substitute for, consolidated net income as a measure of our performance and net cash provided by operating activities as a measure of our liquidity. Additionally, MultiPlan's definition of Unlevered Free Cash Flow is limited, in that it does not represent residual cash flows available for discretionary expenditures, due to the fact that the measure does not deduct the payments required for debt service and other contractual obligations or payments made for business acquisitions.

Adjusted cash conversion ratio is defined as Unlevered Free Cash Flow divided by Adjusted EBITDA. MultiPlan believes that the presentation of the Adjusted cash conversion ratio provides useful information to investors because it is a financial performance measure that shows how much of its Adjusted EBITDA MultiPlan converts into Unlevered Free Cash Flow.

We have not reconciled the forward-looking Adjusted EBITDA guidance included above to the most directly comparable GAAP measure because this cannot be done without unreasonable effort due to the variability and low visibility with respect to certain costs, the most significant of which are incentive compensation (including stock-based compensation), transaction-related expenses (including expenses relating to the business combination), certain fair value measurements and costs related to the uncertainties caused by the global COVID-19 pandemic, which are potential adjustments to future earnings. We expect the variability of these items to have a potentially unpredictable, and a potentially significant, impact on our future GAAP financial results.

 

MULTIPLAN CORPORATION

Unaudited Condensed Consolidated Balance Sheets

(in thousands, except share and per share data)

 

 

September 30,

 

December 31,

2021

2020

Assets

 

 

 

Current assets:

 

 

 

Cash and cash equivalents

$

225,140

 

 

$

126,755

 

Trade accounts receivable, net

66,559

 

 

63,198

 

Prepaid expenses

12,933

 

 

17,708

 

Prepaid taxes

38

 

 

 

Other current assets, net

1,512

 

 

1,193

 

Total current assets

306,182

 

 

208,854

 

Property and equipment, net

202,563

 

 

187,631

 

Operating lease right-of-use assets

26,829

 

 

31,339

 

Goodwill

4,364,705

 

 

4,257,336

 

Other intangibles, net

3,370,204

 

 

3,584,187

 

Other assets

8,310

 

 

14,231

 

Total assets

$

8,278,793

 

 

$

8,283,578

 

Liabilities and Shareholders’ Equity

 

 

 

Current liabilities:

 

 

 

Accounts payable

$

10,497

 

 

$

15,261

 

Accrued interest

80,282

 

 

31,528

 

Accrued taxes

 

 

10,176

 

Operating lease obligation, short-term

6,881

 

 

6,439

 

Accrued compensation

41,475

 

 

21,843

 

Other accrued expenses

28,027

 

 

27,251

 

Total current liabilities

167,162

 

 

112,498

 

Long-term debt

4,893,255

 

 

4,578,488

 

Operating lease obligation, long-term

22,894

 

 

27,499

 

Private Placement Warrants and unvested founder shares

71,145

 

 

106,595

 

Deferred income taxes

768,824

 

 

900,633

 

Other liabilities

177

 

 

 

Total liabilities

5,923,457

 

 

5,725,713

 

Commitments and contingencies (Note 6)

 

 

 

Shareholders’ equity:

 

 

 

Shareholder interests

 

 

 

Preferred stock, $0.0001 par value — 10,000,000 shares authorized; no shares issued

 

Common stock, $0.0001 par value — 1,500,000,000 shares authorized; 665,311,105 and 664,183,318 issued; 645,847,578 and 655,075,355 shares outstanding

67

 

 

66

 

Additional paid-in capital

2,308,344

 

 

2,530,410

 

Retained earnings

200,174

 

 

116,999

 

Treasury stock — 19,463,527 and 9,107,963 shares

(153,249

)

 

(89,610

)

Total shareholders’ equity

2,355,336

 

 

2,557,865

 

Total liabilities and shareholders’ equity

$

8,278,793

 

 

$

8,283,578

 

 

MULTIPLAN CORPORATION

Unaudited Condensed Consolidated Statements of Income (Loss) and Comprehensive Income (Loss)

(in thousands, except share and per share data)

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

2021

 

2020

 

2021

 

2020

Revenues

$

288,212

 

 

$

223,517

 

 

$

819,348

 

 

$

682,419

 

Costs of services (exclusive of depreciation and amortization of intangible assets shown below)

44,588

 

 

147,866

 

 

128,686

 

 

244,445

 

General and administrative expenses

38,221

 

 

176,380

 

 

110,144

 

 

234,147

 

Depreciation

15,783

 

 

15,262

 

 

48,956

 

 

44,903

 

Amortization of intangible assets

85,167

 

 

83,513

 

 

255,042

 

 

250,540

 

Total expenses

183,759

 

 

423,021

 

 

542,828

 

 

774,035

 

Operating income (loss)

104,453

 

 

(199,504

)

 

276,520

 

 

(91,616

)

Interest expense

67,512

 

 

82,275

 

 

195,233

 

 

259,290

 

Interest income

(8

)

 

(81

)

 

(19

)

 

(229

)

Loss on extinguishment of debt

15,823

 

 

 

 

15,823

 

 

 

Loss (gain) on investments

 

 

7,784

 

 

(25

)

 

7,784

 

Change in fair value of Private Placement Warrants and unvested founder shares

(76,636

)

 

 

 

(35,451

)

 

 

Net income (loss) before taxes

97,762

 

 

(289,482

)

 

100,959

 

 

(358,461

)

Provision (benefit) for income taxes

19,565

 

 

(1,080

)

 

23,817

 

 

(11,219

)

Net income (loss)

78,197

 

 

(288,402

)

 

$

77,142

 

 

$

(347,242

)

 

 

 

 

 

 

 

 

Weighted average shares outstanding – Basic1

652,520,691

 

 

415,700,000

 

 

654,414,644

 

 

415,700,000

 

Weighted average shares outstanding – Diluted1

652,882,405

 

 

415,700,000

 

 

654,816,495

 

 

415,700,000

 

 

 

 

 

 

 

 

 

Net income (loss) per share – Basic

$

0.12

 

 

$

(0.69

)

 

$

0.12

 

 

$

(0.84

)

Net income (loss) per share – Diluted

$

0.12

 

 

$

(0.69

)

 

$

0.12

 

 

$

(0.84

)

 

 

 

 

 

 

 

 

Comprehensive income (loss)

78,197

 

 

(288,402

)

 

$

77,142

 

 

$

(347,242

)

1 In accordance with the accounting guidance, the number of shares outstanding prior to the business combination of Polaris Parent Corp. and Churchill Capital Corp III (the “Transactions”) was 415,700,000, which represents the 10 historical shares of Polaris Parent Corp. multiplied by the exchange ratio established in the Transactions (41,570,000:1). At the date of the Transactions, the number of shares outstanding increased to 655,057,192. The increase represents the shares issued by Churchill Capital Corp III prior to the Transactions and the shares issued to PIPE investors at the time of the Transactions, net of shares redeemed and held in treasury upon closing.

 

MULTIPLAN CORPORATION

Unaudited Condensed Consolidated Statements of Cash Flows

(in thousands)

 

 

Nine Months Ended September 30,

 

2021

 

2020

Operating activities:

 

 

 

Net income (loss)

$

77,142

 

 

$

(347,242

)

Adjustments to reconcile net income (loss) to net cash provided by operating activities:

 

 

 

Depreciation

48,956

 

 

44,903

 

Amortization of intangible assets

255,042

 

 

250,540

 

Amortization of the right-of-use asset

5,306

 

 

6,537

 

Stock-based compensation

13,194

 

 

299,628

 

Deferred income taxes

(66,930

)

 

(34,359

)

Non-cash interest costs

9,500

 

 

12,450

 

Loss on extinguishment of debt

15,823

 

 

 

Loss on equity investments

 

 

7,784

 

Loss on disposal of property and equipment

2,366

 

 

77

 

Change in fair value of Private Placement Warrants and unvested founder shares

(35,451

)

 

 

Changes in assets and liabilities, net of assets acquired and liabilities assumed from acquisitions:

 

 

 

Accounts receivable, net

(480

)

 

23,198

 

Prepaid expenses and other assets

4,655

 

 

(34,280

)

Prepaid taxes

(38

)

 

2,130

 

Operating lease obligation

(4,962

)

 

(6,082

)

Accounts payable and accrued expenses and other

47,303

 

 

107,017

 

Net cash provided by operating activities

371,426

 

 

332,301

 

Investing activities:

 

 

 

Purchases of property and equipment

(57,198

)

 

(49,322

)

Proceeds from sale of investment

5,641

 

 

 

Purchase of equity investments

 

 

(101,006

)

HST Acquisition, net of cash acquired

36

 

 

 

DHP Acquisition, net of cash acquired

(149,676

)

 

 

Net cash used in investing activities

(201,197

)

 

(150,328

)

Financing activities:

 

 

 

Repayments of Term Loan G

(2,341,000

)

 

 

Issuance of Term Loan B

1,298,951

 

 

 

Issuance of 5.500% Senior Secured Notes

1,034,597

 

 

 

Taxes paid on settlement of vested share awards

(3,312

)

 

 

Borrowings on revolving credit facility

 

 

98,000

 

Repayment of revolving credit facility

 

 

(98,000

)

Purchase of treasury stock

(61,080

)

 

 

Borrowings on finance leases, net

 

 

9

 

Net cash (used in) provided by financing activities

(71,844

)

 

9

 

Net increase in cash and cash equivalents

98,385

 

 

181,982

 

Cash and cash equivalents at beginning of period

126,755

 

 

21,825

 

Cash and cash equivalents at end of period

$

225,140

 

 

$

203,807

 

Noncash investing and financing activities:

 

 

 

Purchases of property and equipment not yet paid

$

6,160

 

 

$

4,237

 

Operating lease right-of-use assets obtained in exchange for operating lease liabilities

$

795

 

 

$

10,158

 

Supplemental disclosure of cash flow information:

 

 

 

Cash paid during the period for:

 

 

 

Interest

$

(136,951

)

 

$

(194,074

)

Income taxes, net of refunds

$

(101,635

)

 

$

(4,415

)

 

MULTIPLAN CORPORATION

Calculation of EBITDA and Adjusted EBITDA

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

(in thousands)

2021

 

2020

 

2021

 

2020

 

 

 

 

 

 

 

 

Net income (loss)

$

78,197

 

 

$

(288,402

)

 

$

77,142

 

 

$

(347,242

)

Adjustments:

 

 

 

 

 

 

 

Interest expense

67,512

 

 

82,275

 

 

195,233

 

 

259,290

 

Interest income

(8

)

 

(81

)

 

(19

)

 

(229

)

Income tax provision (benefit)

19,565

 

 

(1,080

)

 

23,817

 

 

(11,219

)

Depreciation

15,783

 

 

15,262

 

 

48,956

 

 

44,903

 

Amortization of intangible assets

85,167

 

 

83,513

 

 

255,042

 

 

250,540

 

Non-income taxes

105

 

 

415

 

 

1,107

 

 

1,335

 

EBITDA

$

266,321

 

 

$

(108,098

)

 

$

601,278

 

 

$

197,378

 

Adjustments:

 

 

 

 

 

 

 

Other expenses

1,685

 

 

297

 

 

2,396

 

 

566

 

Integration expenses

4,875

 

 

715

 

 

9,563

 

 

743

 

Change in fair value of Private Placement Warrants and unvested founder shares

(76,636

)

 

 

 

(35,451

)

 

 

Transaction-related expenses

1,541

 

 

2,464

 

 

7,972

 

 

5,162

 

Loss (gain) on investments

 

 

7,784

 

 

(25

)

 

7,784

 

Loss on extinguishment of debt

15,823

 

 

 

 

15,823

 

 

 

Stock-based compensation

4,752

 

 

262,356

 

 

13,194

 

 

299,628

 

Adjusted EBITDA

$

218,361

 

 

$

165,518

 

 

$

614,750

 

 

$

511,261

 

 

Calculation of Unlevered Free Cash Flow and Adjusted Cash Conversion Ratio

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

(in thousands)

2021

 

2020

 

2021

 

2020

 

 

 

 

 

 

 

 

Net cash provided by operating activities

$

167,037

 

 

$

140,434

 

 

$

371,426

 

 

$

332,301

 

Purchases of property and equipment

(20,411

)

 

(14,456

)

 

(57,198

)

 

(49,322

)

Interest paid

13,836

 

 

26,238

 

 

136,951

 

 

194,074

 

Unlevered Free Cash Flow

$

160,462

 

 

152,216

 

 

$

451,179

 

 

$

477,053

 

 

 

 

 

 

 

 

 

Adjusted EBITDA

$

218,361

 

 

$

165,518

 

 

$

614,750

 

 

$

511,261

 

Adjusted Cash Conversion Ratio

73

%

 

92

%

 

73

%

 

93

%

 

 

 

 

 

 

 

 

Net cash used in investing activities

(20,347

)

 

(115,462

)

 

(201,197

)

 

(150,328

)

Net cash (used in) provided by financing activities

(69,521

)

 

(25

)

 

(71,844

)

 

9

 

 

Contacts

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.